A 12-page Executive Summary offering summary highlights for 22 Accountable Care Organizations and ACO solutions companies regarding their successes during the most recent MSSP performance year.
PharmExec's Top Ten Pharma Companies 2019
- Pfizer - $45.302(B) Rx Sales
- Roche - $44.552(B) Rx Sales
- Novartis - $43.481(B) Rx Sales
- Johnson & Johnson - $38.815(B) Rx Sales
- Merck & Co. - $37.353(B) Rx Sales
- Sanofi - $35.121(B) Rx Sales
- AbbVie - $32.067(B) Ex Sales
- GlaxoSmithKline - $30.645(B) Rx Sales
- Amgen - $22.533(B) Rx Sales
- Gilead Sciences - $21.677(B) Rx Sales
Source: Pharmexec - http://www.pharmexec.com/pharm-execs-top-50-companies-2019
ACO Performance Case Studies
*By signing up for this offer you agree to receive the Accountable Care bulletin and the HealthExecWire news release bulletin.
Accountable Care
Offerings
Value-Based Payments
Offerings
Analytics
Offerings
Population Health
Offerings
Payers & Providers
Offerings